Skip to Content
Stock Analyst Update

BP Announces Share Buyback Program

We increased our fair value estimate after news of the program that will cover scrip dilution.


In a positive development, in its third-quarter earnings release,  BP announced a share-repurchase program to cover the dilutive effect of its scrip starting in the fourth quarter of 2017. The announcement demonstrates the progress BP has made in reducing its break-even price to about $50/barrel for 2018. While the decision lacks the conviction of fully restoring the cash dividend, it does preserve flexibility in the event oil prices do not hold above $45/bbl, a level down to which management seems confident it can still repurchase the necessary shares. Management also indicated some investors prefer the efficiency of a scrip dividend option. However, in the long term, we’d expect a restoration of the full cash dividend along with potentially accretive share repurchases as BP’s break-even level trends below $50/bbl in the coming years and oil prices rise. This price excludes Gulf of Mexico payments, which BP plans to fund with asset sales proceeds. While totaling $5.5 billion this year, they should become more manageable as they fall to about $2 billion next year and to $1 billion a year in 2019 and beyond.

BP's operating results were strong in the third quarter of 2017. Underlying profits grew $1 billion to $1.9 billion compared with last year. On the upstream, 11% higher production volumes from major project ramp-ups and increased price realizations more than offset higher depreciation and amortization charges. Refining and marketing results doubled compared with last year, as higher refining margins outweighed smaller crude differentials in the U.S.

We updated our analysis with third-quarter results, slightly lower full-year capital expenditures, and improved up- and downstream earnings. As a result, we increase our fair value estimate to GBX 475/$38 from GBX 465/$36. Our moat rating remains unchanged at no-moat.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Allen Good does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.